1 |
CH0113817123 |
Bellevue Biotech DT CHF |
-3,39 % |
+18,82 % |
-0,31 |
2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-4,23 % |
+18,50 % |
-0,36 |
3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-4,45 % |
+18,48 % |
-0,37 |
4 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-4,54 % |
+18,33 % |
-0,38 |
5 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-4,64 % |
+18,29 % |
-0,38 |
|
31 |
LU1176840327 |
Protea Fund - Sectoral Biotech Opportunities Fund PF USD |
-5,95 % |
+17,48 % |
-0,48 |
|
73 |
DE000DWS2UA1 |
DWS ESG Biotech TFC |
-12,43 % |
+20,11 % |
-0,74 |
74 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-16,50 % |
+19,62 % |
-0,96 |
75 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
-16,05 % |
+20,74 % |
-0,89 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-34,96 % |
+30,36 % |
-1,23 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-35,10 % |
+30,34 % |
-1,23 |